Reductive stimulation response drug carrier containing carbon nano cage and preparation method and application thereof

A stimuli-responsive, carbon nano-cage technology, applied in medical preparations, drug combinations, and pharmaceutical formulations containing active ingredients, can solve problems such as full release of difficult drugs and no treatment of tumors, and achieve improved drug release and high drug loading. ability, the effect of inhibiting tumor growth

Active Publication Date: 2016-11-09
TONGJI UNIV
View PDF4 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In addition, reducing the stimulus-responsive carrier, the way to stimulate drug release in animals is mainly that the reducing agent glutathione in tumor tissue and cells breaks the disulfide bond in the carrie

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Reductive stimulation response drug carrier containing carbon nano cage and preparation method and application thereof
  • Reductive stimulation response drug carrier containing carbon nano cage and preparation method and application thereof
  • Reductive stimulation response drug carrier containing carbon nano cage and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Reductive stimulus-responsive drug carrier containing carbon nanocage and preparation method thereof:

[0040] Synthesis of "carbon nanocages coated with polyamide-amine dendrimers" in microemulsions (the polymer is G0 type PAMAM-NH with terminal groups of amino groups 2 ):

[0041] (1) Specific synthesis method

[0042] A. Synthesis of carbon nanocages (Carbon nanocage, CNC) by high temperature pyrolysis

[0043] Weigh 1 g of ferrous oxalate and dissolve it in 10 mL of absolute ethanol, and seal the solution in a stainless steel reaction kettle. This reaction kettle is placed in muffle furnace at 550 DEG C of heating reaction, stops heating after 12h, naturally cools to room temperature in furnace. The sample was taken out, placed in a 50 mL round bottom flask, 30 mL of 10% hydrochloric acid was added, and refluxed at 70 °C for 12 h. The reaction solution was centrifuged, and the precipitate was collected and washed 3 times with deionized water. Add 30 mL of nitri...

Embodiment 2

[0070] Synthesis of "carbon nanocages coated with polyamide-amine dendrimers" in microemulsion (the polymer is G0-type PAMAM-COOH whose end group is carboxyl group):

[0071] (1) Specific synthesis method

[0072] A. Preparation of Microemulsion

[0073] Mix cyclohexane (45 mL), Triton X-100 (15 mL), and n-hexanol (15 mL), and their volume ratio is about: n-hexanol: Triton X-100=1:1, cyclohexane:( n-hexanol+Triton X-100)=3:2, this mixed solution is called the microemulsion pre-liquid, and then prepare the following microemulsion:

[0074] ◆Preparation of microemulsion of CNC with carboxyl groups on the surface: Prepare 1 mL of CNC aqueous dispersion with a concentration of 2 mg / mL, ultrasonically treat it for 10 min, mix it with 10 mL of microemulsion pre-liquid, and shake at room temperature for 2-3 min , to obtain CNC microemulsion;

[0075] ◆ Preparation of PAMAM-COOH microemulsion: Prepare 2 mL of PAMAM-COOH water with a concentration of 100 mg / mL, then mix it with 20 m...

Embodiment 3

[0086] (1) specific synthesis method

[0087] A. Preparation of microemulsions

[0088] Mix cyclohexane (60 mL), Triton X-100 (15 mL), and n-hexanol (5 mL), and their volume ratio is about: n-hexanol: Triton X-100=1:3, cyclohexane:( n-hexanol+Triton X-100)=3:1, then prepare the following microemulsion with the microemulsion pre-liquid:

[0089] ◆Preparation of microemulsion of CNC with carboxyl groups on the surface: Prepare 1 mL of CNC aqueous dispersion with a concentration of 0.05 mg / mL, ultrasonically treat it for 10 min, mix it with 10 mL of microemulsion precursor, shake at room temperature for 2-3 min, to obtain CNC microemulsion;

[0090] ◆ Preparation of PAMAM-COOH microemulsion: Prepare 2 mL of PAMAM-COOH water with a concentration of 0.25 mg / mL, then mix with 20 mL of microemulsion pre-liquid, and shake at room temperature for 2-3 minutes to obtain PAMAM-COOH microemulsion;

[0091] ◆Preparation of EDC / NHS microemulsion: Weigh 10 mg of EDC and 10 mg of NHS, disso...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a reductive stimulation response drug carrier containing carbon nano cages. The carbon nano cages (CNC) are used as a core, dendritic macromolecules coat the surface of each CNC, the CNCs are connected through disulfide bonds, the macromolecules are connected through disulfide bonds, and the CNCs and the macromolecules are connected through disulfide bonds; the dendritic macromolecules are polyamide-amide dendritic macromolecules (PAMAM) of low generation G0, G1, G2 and/or G3, and are PAMAM-NH2 with amino groups as terminal groups or PAMAM-COOH with carboxy groups as terminals. The invention further provides a preparation method and application thereof. The nano carrier has high loading capacity and can sensitively release drug under stimulation of a reductant like glutathione, and drug release can be promoted through laser irradiation. Tumor tissue contains high-concentration glutathione, so that drug carrying particles have important medicinal prospect in tumor targeted treatment.

Description

technical field [0001] The present invention relates to a reducing stimulus-responsive drug carrier containing carbon nanocages and its preparation method and application, in particular to a carbon nanocage (abbreviated as CNC) coated with dendritic polymers and its preparation method and application. Nanocomposite particles formed by cross-linking dendritic polymers and CNC, and a preparation method thereof. The nanocomposite particles have the characteristics of stimuli-responsive drug release, especially reduction-stimuli-responsive drug release, and belong to biological materials. field. Background technique [0002] Carbon-based nanomaterials such as graphene, carbon nanotubes, nanodiamonds, and fullerenes have important application prospects in the field of drug delivery. Their common characteristics are good biocompatibility and high drug loading capacity. In order to make the drug release slowly, it is often desired that the drug carrier has a three-dimensional poro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/51A61K47/04A61K47/34A61K45/06A61K41/00A61K31/513A61K33/24A61P35/00
CPCA61K9/0004A61K9/5115A61K9/5146A61K31/513A61K33/24A61K41/0052A61K41/0071A61K45/06A61K2300/00
Inventor 储茂泉韩春哲
Owner TONGJI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap